Mugusi, S., & Burhenne, J. (2018). Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin. European journal of clinical pharmacology, 74(11), . https://doi.org/10.1007/s00228-018-2499-0
Chicago Style (17th ed.) CitationMugusi, Sabina, and Jürgen Burhenne. "Neuropsychiatric Manifestations Among HIV-1 Infected African Patients Receiving Efavirenz-based CART with or Without Tuberculosis Treatment Containing Rifampicin." European Journal of Clinical Pharmacology 74, no. 11 (2018). https://doi.org/10.1007/s00228-018-2499-0.
MLA (9th ed.) CitationMugusi, Sabina, and Jürgen Burhenne. "Neuropsychiatric Manifestations Among HIV-1 Infected African Patients Receiving Efavirenz-based CART with or Without Tuberculosis Treatment Containing Rifampicin." European Journal of Clinical Pharmacology, vol. 74, no. 11, 2018, https://doi.org/10.1007/s00228-018-2499-0.